Shozo Fukuda is the Manager of the Crystal Polymorphism Group within Corporate NV Creation at NGK Corporation, where he leads international sales and marketing for the company’s Crystal Polymorphism Screening Service. In this role, he drives global business development initiatives, working to expand the service’s reach and impact across international pharmaceutical markets.

Fukuda played a pivotal role in the successful launch of the Crystal Polymorphism Screening Service, contributing to both its strategic planning and execution. Prior to expanding his focus globally, he was responsible for sales and marketing efforts in Japan, where he significantly increased domestic visibility and adoption of the service.

With over 20 years of experience in the pharmaceutical industry, Fukuda brings deep expertise in sales strategy, customer engagement, and team leadership. His extensive background has enabled him to effectively bridge scientific innovation with market needs, positioning NGK’s offerings for continued growth and success worldwide.